Article Information
History
- July 22, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Science for Life Laboratory (SciLifeLab), Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
- 2Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu, China
- 3Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China
- 4Danish Cancer Institute, Genome Integrity Group, Copenhagen, Denmark
- 5Science for Life Laboratory (SciLifeLab), Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- ↵*Corresponding author, Sean G Rudd (sean.rudd{at}scilifelab.se)
Posted July 22, 2024.
Glutamine-addiction in cisplatin resistant cancer cells is mediated by SLC7A11 and can be targeted with asparaginase therapy
